Last reviewed · How we verify
ARIPiprazole 30 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
ARIPiprazole 30 MG (ARIPiprazole 30 MG) — Ain Shams University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ARIPiprazole 30 MG TARGET | ARIPiprazole 30 MG | Ain Shams University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ARIPiprazole 30 MG CI watch — RSS
- ARIPiprazole 30 MG CI watch — Atom
- ARIPiprazole 30 MG CI watch — JSON
- ARIPiprazole 30 MG alone — RSS
Cite this brief
Drug Landscape (2026). ARIPiprazole 30 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/aripiprazole-30-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab